2024-12-01 2025-11-30 false Capium Accounts Production 1.1 11072056 2024-12-01 2025-11-30 11072056 bus:AbridgedAccounts 2024-12-01 2025-11-30 11072056 bus:FRS102 2024-12-01 2025-11-30 11072056 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 11072056 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 11072056 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 11072056 2024-12-01 2025-11-30 11072056 2025-11-30 11072056 bus:RegisteredOffice 2024-12-01 2025-11-30 11072056 core:WithinOneYear 2025-11-30 11072056 core:AfterOneYear 2025-11-30 11072056 1 2024-12-01 2025-11-30 11072056 bus:Director1 2024-12-01 2025-11-30 11072056 bus:Director1 2025-11-30 11072056 bus:Director1 2023-12-01 2024-11-30 11072056 2023-12-01 11072056 bus:LeadAgentIfApplicable 2024-12-01 2025-11-30 11072056 2023-12-01 2024-11-30 11072056 2024-11-30 11072056 core:WithinOneYear 2024-11-30 11072056 core:AfterOneYear 2024-11-30 11072056 bus:EntityAccountantsOrAuditors 2023-12-01 2024-11-30 11072056 bus:OrdinaryShareClass1 2024-12-01 2025-11-30 11072056 bus:OrdinaryShareClass1 2025-11-30 11072056 bus:OrdinaryShareClass1 2023-12-01 2024-11-30 11072056 bus:OrdinaryShareClass1 2024-11-30 11072056 core:CostValuation core:Non-currentFinancialInstruments 2025-11-30 11072056 core:CostValuation core:Non-currentFinancialInstruments 2024-11-30 11072056 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-11-30 11072056 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 11072056 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 11072056 core:Non-currentFinancialInstruments 2025-11-30 11072056 core:Non-currentFinancialInstruments 2024-11-30 11072056 core:ShareCapital 2025-11-30 11072056 core:ShareCapital 2024-11-30 11072056 core:RetainedEarningsAccumulatedLosses 2025-11-30 11072056 core:RetainedEarningsAccumulatedLosses 2024-11-30 11072056 dpl:Item1 2024-12-01 11072056 dpl:Item1 2025-11-30 11072056 dpl:Item1 2023-12-01 11072056 dpl:Item1 2024-11-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 11072056
England and Wales

 

 

 

MAVENS HEALTH LIMITED



Abridged Accounts
 


Period of accounts

Start date: 01 December 2024

End date: 30 November 2025
Report to the directors on the preparation of the unaudited statutory accounts of MAVENS HEALTH LIMITED year ended 30 November 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of MAVENS HEALTH LIMITED for the year ended 30 November 2025 which comprise the Profit and Loss Account, the Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

This report is made solely to the Directors of MAVENS HEALTH LIMITED, as a body, in accordance with the terms of our engagement. Our work has been undertaken solely to prepare for your approval the accounts of MAVENS HEALTH LIMITED

To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than MAVENS HEALTH LIMITED and its Directors as a body for our work or for this report.
It is your duty to ensure that MAVENS HEALTH LIMITED has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and Profit of MAVENS HEALTH LIMITED.

You consider that MAVENS HEALTH LIMITED is exempt from the statutory audit requirement for the year ended 30 November 2025. We have not been instructed to carry out an audit or a review of the accounts of MAVENS HEALTH LIMITED. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.




....................................................
LIGHTHALL CONSULT LTD
UNIT 128 FIRST FLOOR
415 HIGH STREET
LONDON
E15 4QZ
28 August 2026
1
 
 
Notes
 
2025
£
  2024
£
Current assets      
Cash at bank and in hand 265,574    225,421 
Creditors: amount falling due within one year (13,089)   (10,800)
Net current assets 252,485    214,621 
 
Total assets less current liabilities 252,485    214,621 
Net assets 252,485    214,621 
 

Capital and reserves
     
Called up share capital 3 100    100 
Profit and loss account 252,385    214,521 
Shareholders' funds 252,485    214,621 
 


For the year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 28 August 2026 and were signed by:


-------------------------------
Adegboyega TAYO
Director
2
General Information
MAVENS HEALTH LIMITED is a private company, limited by shares, registered in England and Wales, registration number 11072056, registration address 12 WESTERN ROAD, RAYLEIGH UNITED KINGDOM, SS6 7AX.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
2.

Average number of employees

Average number of employees during the year was 0 (2024 : 0).
3.

Share Capital

Allotted, called up and fully paid
2025
£
  2024
£
100 Class A shares of £1.00 each 100    100 
100    100 

3